クローン病に関連したIgA媒介のグッドパストル病の例外的なケース
Rebecca Ryan1, Thomas Fairhead2, Sophie Seager2
1Nephrology, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.
Kidney medicine
|February 16, 2026
まとめ
クローン病に関連した,IgA媒介の希少な抗グロメルーラ基底膜疾患の変種が観察されました. このユニークな症例は,免疫抑制なしで解決し,腎臓肺症候群の新しい診断および治療の可能性を示唆しました.
科学分野:
- ネフロロジーは腎臓科です.
- 免疫学 免疫学とは
- 胃腸内科 胃腸内科
背景:
- 抗グルメラ底膜 (GBM) 疾患は通常IgG媒介で,肺出血とグルメロネフリス (グッドパストゥール病) を引き起こします.
- IgA媒介の抗GBM疾患はまれで,通常,攻撃的な免疫抑制を必要とする.
研究 の 目的:
- IgA媒介の抗GBM疾患の新規症例を記述する.
- クローン病とこの変異体との潜在的な関連性を調査する.
- 免疫抑制なしで解決したケースを強調するために.
主な方法:
- クロンの大腸炎を患った53歳の男性で,急性腎臓損傷と血症を呈した症例報告.
- 抗GBM抗体に対する血清学的検査.
- 腎臓の生検で,IgAの蓄積を検出するために,免疫光検査を行います.
主要な成果:
- 患者は,オリゴ・アヌリック性急性腎臓損傷と血症を呈した.
- 腎臓生検は,抗GBM血清学が陰性であったにもかかわらず,線形IgA沉積によるネクロチズする半月状グルメロネフライトを示した.
- この状態は,免疫抑制療法なしで自発的に治りました.
結論:
- クロンの大腸炎に関連した新しいIgA媒介の抗GBM疾患の変種が提示されています.
- 炎症性腸疾患における異常なIgAグリコシレーションは,このユニークな抗GBMプロセスに寄与する可能性があります.
- このケースは,いくつかの血清陰性肺腎症候群における非免疫抑制管理の可能性を示唆しています.
キーワード:
アンチグロメルーラ基底膜疾患クローン病はクローン病です.グッドパストゥール症候群 (Goodpasture syndrome) とは,グッドパストゥール症候群 (goodpasture syndrome) とは,グッドパストゥール症候群 (goodpasture syndrome) とは,グッドパストゥール症候群 (goodpasture syndrome) とは,グッドパストゥール症候群 (goodpasture syndrome) とは,グッドパストゥール症候群 (goodpasture syndrome) とは,グッドパストゥール症候群 (goodpasture syndrome) とは,グッドパストゥール症候群 (goodpasture syndrome) とは,グッドパストゥール症候群 (goodpasture syndrome) とは,グッドパストゥール症候群 (goodpasture syndrome) とは,グッドパストゥール症候群 (goodpasture syndrome) とは,グッドパストゥール症候群 (goodpasture syndrome) とは,IgA媒介の抗-GBM疾患である.急性腎臓損傷による急性腎臓損傷アンチ-GBMM でした.抗グロメルーラ基底膜疾患である.半月状のグルメルーロネフリス炎イムノフロアセンスを使います.免疫グロブリンA炎症性腸疾患とは腎臓バイオプシーによる腎臓生検線形IgA堆積は,線形IgA堆積というものです.肺出血による肺出血です.肺腎症候群 肺腎症候群とは急激に進行するグルメルノネフライト.血清否定的な抗GBM疾患である.関連する概念動画
Inflammatory Bowel Disease II: Crohn's Disease
1.3K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K
Gastritis-II: Pathophysiology
1.4K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.4K
Chronic Bowel Disorders: Introduction
817
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
817
Inflammatory Bowel Disease I: Ulcerative Colitis
1.2K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.2K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
600
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
600
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
915
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
915


